SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10064	Companies
205734	Keywords
135990	Articles
109082	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/07/2024 at 17:30, 1 year 3 months ago

Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
Positive phase 3 study shows rilzabrutinib benefits in ITP patients. Results include platelet response, reduced bleeding, improved quality of life. Safety and efficacy highlighted

Phase 3 Study Rilzabrutinib ITP BTK Inhibitor Patient Benefit
BRIEF

published on 12/06/2024 at 07:35, 1 year 3 months ago

Sanofi Publishes Revised Financial Statements Excluding Opella

Financial Statements Biopharma Sanofi 2024 Results Opella
BRIEF

published on 12/06/2024 at 07:35, 1 year 3 months ago

Sanofi publie ses états financiers révisés excluant Opella

États Financiers Résultats 2024 Biopharma Sanofi Opella
PRESS RELEASE

published on 12/06/2024 at 07:30, 1 year 3 months ago

Press Release: Availability of the revised financial statements for Sanofi excluding Opella
Sanofi releases revised financial statements excluding Opella. The adjustments classify Opella as discontinued operations, aligning with Sanofi's transition to a biopharma company. Q4 2024 results expected on Jan 30, 2025

Sanofi Discontinued Operations Opella Revised Financial Statements Biopharma Company
PRESS RELEASE

published on 12/06/2024 at 07:30, 1 year 3 months ago

Communiqué de presse : Mise en ligne des états financiers révisés de Sanofi hors Opella
Publication des états financiers révisés de Sanofi, hors Opella, suite à la cession de 50% à CD&R. Sanofi se recentre sur la biopharmacie et l'innovation

Cession États Financiers Sanofi Opella Biopharmacie
PRESS RELEASE

published on 10/25/2024 at 07:30, 1 year 4 months ago

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance
PRESS RELEASE

published on 10/25/2024 at 07:30, 1 year 4 months ago

Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue par une séquence des ventes de vaccins plus favorable qu’anticipée; Sanofi relève ses perspectives de BNPA des activités 2024 suite à la forte performance
BRIEF

published on 10/24/2024 at 14:05, 1 year 4 months ago

Positive Phase 3 Data for Dupixent in Chronic Spontaneous Urticaria Released

Dupixent Chronic Spontaneous Urticaria Phase 3 Data ACAAI Presentation Treatment Innovation
BRIEF

published on 10/24/2024 at 14:05, 1 year 4 months ago

Publication de données positives de phase 3 pour Dupixent dans l'urticaire chronique spontanée

Dupixent Urticaire Chronique Spontanée Données De La Phase 3 Présentation De L'ACAAI Innovation En Matière De Traitement
PRESS RELEASE

published on 10/24/2024 at 14:00, 1 year 4 months ago

Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI
Dupixent phase 3 data in chronic spontaneous urticaria presented at ACAAI shows reduced itch and hive activity, potential new treatment for CSU patients

Dupixent Chronic Spontaneous Urticaria ACAAI Phase 3 Data Targeted Treatment

Accesswire

Published on 03/23/2026 at 13:05, 53 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 1 hour 26 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 1 hour 28 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 12:30, 1 hour 28 minutes ago

High Tide Resources Announces Closing of Concurrent Non-Brokered Private Placements for Gross Proceeds of $8.3 Million
Published on 03/23/2026 at 12:20, 1 hour 38 minutes ago

Guanajuato Silver Adds Veteran Mine Operator to Board of Directors

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 13:35, 23 minutes ago

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.661 Million Tokens, and Total Crypto and Total Cash Holdings of $11.0 Billion
Published on 03/23/2026 at 13:35, 23 minutes ago

Ole Book to become Borussia Dortmund’s new Director Sport
Published on 03/23/2026 at 13:05, 53 minutes ago

Cambrex Advances US and European Expansions
Published on 03/23/2026 at 13:02, 55 minutes ago

Directorate change
Published on 03/23/2026 at 12:40, 1 hour 18 minutes ago

EQS-Adhoc: Ströer plans a dividend of €1.85 for fiscal year 2025 and approves a share buyback program of up to €50 million

Les Echos

Published on 03/23/2026 at 08:10, 5 hours 48 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 18 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 18 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 19 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 19 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE